PTC Therapeutics, Inc.
TABLET FOR USE IN TREATING HUNTINGTON'S DISEASE AND METHOD OF MAKING THE SAME

Abstract:

The present description relates to a tablet formulation of 7-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-5-fluoro-3-(piperidin-4-yl)b- enzo[e][1,2,4]triazine, a compound for use in treating Huntington's disease, and a method of making the same.